Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa.
作者信息
Duga Alemayehu Lelisa, Ngongo Ngashi, Fallah Mosoka Papa, Figueras Albert, Kilowe Carlos, Murtala Jibril, Kayumba Kizito, Angasa Tedi, Kuba Aminu, Kabwe Patrick Chanda, Dereje Nebiyu, Raji Tajudeen, Ndembi Nicaise, Kaseya Jean
机构信息
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
Doctoral School Societies Politics, Public Health, Pharmacoepidemiology and Pharmacovigilance, University of Bordeaux, Bordeaux, France.
出版信息
BMJ Glob Health. 2024 Oct 9;9(10):e015445. doi: 10.1136/bmjgh-2024-015445.
Abstract
摘要
相似文献
1
Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa.
BMJ Glob Health. 2024 Oct 9;9(10):e015445. doi: 10.1136/bmjgh-2024-015445.
2
WHO's rollout of malaria vaccine in Africa: can safety questions be answered after only 24 months?
BMJ. 2020 Jan 24;368:l6920. doi: 10.1136/bmj.l6920.
3
Malaria vaccination in Africa: A mini-review of challenges and opportunities.
Medicine (Baltimore). 2024 Jun 14;103(24):e38565. doi: 10.1097/MD.0000000000038565.
4
Setting up a data system for monitoring malaria vaccine introduction readiness and uptake in 42 health districts in Cameroon.
BMJ Glob Health. 2024 Apr 4;9(4):e015312. doi: 10.1136/bmjgh-2024-015312.
5
Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.
Parasite Immunol. 1997 Dec;19(12):579-81. doi: 10.1046/j.1365-3024.1997.d01-171.x.
6
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
Malar J. 2011 Aug 4;10:224. doi: 10.1186/1475-2875-10-224.
7
Vaccines for malaria: how close are we?
Annu Rev Med. 2012;63:345-57. doi: 10.1146/annurev-med-022411-192402. Epub 2011 Nov 10.
8
First proven malaria vaccine rolled out in Africa - but doubts linger.
Nature. 2019 May;569(7754):14-15. doi: 10.1038/d41586-019-01342-z.
9
Malaria vaccines in Africa.
Acta Trop. 2003 Oct;88(2):153-9. doi: 10.1016/s0001-706x(03)00200-6.
10
Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective.
Malar J. 2010 Apr 20;9:103. doi: 10.1186/1475-2875-9-103.
本文引用的文献
1
Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries.
Commun Med (Lond). 2023 Oct 13;3(1):144. doi: 10.1038/s43856-023-00373-y.
2
Drug safety in Africa: a review of systems and resources for pharmacovigilance.
Expert Opin Drug Saf. 2023 Jul-Dec;22(10):891-895. doi: 10.1080/14740338.2023.2251375. Epub 2023 Sep 7.
3
COVID-19 vaccine hesitancy in Africa: a scoping review.
Glob Health Res Policy. 2022 Jul 19;7(1):21. doi: 10.1186/s41256-022-00255-1.
4
Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa.
Br J Clin Pharmacol. 2023 Feb;89(2):491-509. doi: 10.1111/bcp.15193. Epub 2022 Feb 9.
5
Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia.
BMC Med Inform Decis Mak. 2021 Dec 15;21(1):349. doi: 10.1186/s12911-021-01710-8.
6
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.
Drug Saf. 2021 Jun;44(6):615-617. doi: 10.1007/s40264-021-01068-w. Epub 2021 May 8.
7
Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
BMC Public Health. 2021 Jan 21;21(1):187. doi: 10.1186/s12889-021-10169-1.
8
The importance of effective risk communication and transparency: lessons from the dengue vaccine controversy in the Philippines.
J Public Health Policy. 2020 Sep;41(3):252-267. doi: 10.1057/s41271-020-00232-3.
9
Real-time vaccine safety surveillance for the early detection of adverse events.
Med Care. 2007 Oct;45(10 Supl 2):S89-95. doi: 10.1097/MLR.0b013e3180616c0a.
Zotero 插件